151 related articles for article (PubMed ID: 8854471)
1. [Pulsed high-dose dexamethasone in resistant immune thrombocytopenic purpura].
Bulvik S; Ben-Tal O; Shimoni Z; Eldor A
Harefuah; 1996 Jul; 131(1-2):18-20, 71. PubMed ID: 8854471
[TBL] [Abstract][Full Text] [Related]
2. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy.
Andersen JC
N Engl J Med; 1994 Jun; 330(22):1560-4. PubMed ID: 8177245
[TBL] [Abstract][Full Text] [Related]
3. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Cheng Y; Wong RS; Soo YO; Chui CH; Lau FY; Chan NP; Wong WS; Cheng G
N Engl J Med; 2003 Aug; 349(9):831-6. PubMed ID: 12944568
[TBL] [Abstract][Full Text] [Related]
4. Effect of high-dose dexamethasone in prednisone-resistant autoimmune thrombocytopenic purpura (ITP).
Dubbeld P; van der Heul C; Hillen HF
Neth J Med; 1991 Aug; 39(1-2):6-10. PubMed ID: 1961352
[TBL] [Abstract][Full Text] [Related]
5. Pulsed intravenous high-dose dexamethasone in adults with chronic idiopathic thrombocytopenic purpura.
Stasi R; Brunetti M; Pagano A; Stipa E; Masi M; Amadori S
Blood Cells Mol Dis; 2000 Dec; 26(6):582-6. PubMed ID: 11112391
[TBL] [Abstract][Full Text] [Related]
6. High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults.
Borst F; Keuning JJ; van Hulsteijn H; Sinnige H; Vreugdenhil G
Ann Hematol; 2004 Dec; 83(12):764-8. PubMed ID: 15309522
[TBL] [Abstract][Full Text] [Related]
7. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
8. High-dose cycles of dexamethasone in idiopathic thrombocytopenic purpura.
Calabresi AR; Veith RW; Rigby PG
J La State Med Soc; 2004; 156(5):269-72. PubMed ID: 15554097
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
Vianelli N; Galli M; de Vivo A; Intermesoli T; Giannini B; Mazzucconi MG; Barbui T; Tura S; Baccaranion M;
Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672
[TBL] [Abstract][Full Text] [Related]
10. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
Schweizer C; Reu FJ; Ho AD; Hensel M
Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
[TBL] [Abstract][Full Text] [Related]
11. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.
Vancine-Califani SM; De Paula EV; Ozelo MC; Orsi FL; Fabri DR; Annichino-Bizzacchi JM
Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360
[TBL] [Abstract][Full Text] [Related]
13. Short-course high-dose dexamethasone therapy for chronic idiopathic thrombocytopenic purpura in children.
Yadav D; Chandra J; Sharma S; Singh V
J Trop Pediatr; 2010 Dec; 56(6):446-7. PubMed ID: 20388659
[TBL] [Abstract][Full Text] [Related]
14. Splenectomy results in patients with idiopathic thrombocytopenic purpura: 10 years of experience in Turgut Ozal Medical Center.
Ismet A; Irfan K; Emin K; AlI EM; Ramazan U; Mustafa B; Onur O
Clin Lab Haematol; 2004 Jun; 26(3):211-4. PubMed ID: 15163320
[TBL] [Abstract][Full Text] [Related]
15. Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long-term results.
Maloisel F; Andrès E; Zimmer J; Noel E; Zamfir A; Koumarianou A; Dufour P
Am J Med; 2004 May; 116(9):590-4. PubMed ID: 15093754
[TBL] [Abstract][Full Text] [Related]
16. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
[TBL] [Abstract][Full Text] [Related]
17. Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses.
Kumar S; Diehn FE; Gertz MA; Tefferi A
Ann Hematol; 2002 Jun; 81(6):312-9. PubMed ID: 12107560
[TBL] [Abstract][Full Text] [Related]
18. Experience with high dose dexamethasone in the treatment of chronic symptomatic immune thrombocytopaenia.
Van Riet FA; Wessels G; Hesseling PB
East Afr Med J; 1999 Oct; 76(10):571-4. PubMed ID: 10734508
[TBL] [Abstract][Full Text] [Related]
19. Splenectomy for idiopathic thrombocytopenic purpura: a five-year retrospective review.
Gibson M; Sehon JK; White S; Zibari GB; Johnson LW
Am Surg; 2000 Oct; 66(10):952-4; discussion 955. PubMed ID: 11261623
[TBL] [Abstract][Full Text] [Related]
20. Rituximab in the treatment of relapsing idiopathic thrombocytopenic purpura.
Riksen NP; Keuning JJ; Vreugdenhil G
Neth J Med; 2003 Jul; 61(7):262-5. PubMed ID: 14567524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
